EAS Clinical Trial

Welcome. You may be wondering whether the Electric Acoustic Hearing Implant System clinical trial is the best choice for you or someone in your life. The following pages are designed to address many of the questions you may have concerning the EAS Hearing Implant System.

The EAS™ Hearing Implant System is the world’s first hearing implant solution for combined Electric Acoustic Stimulation (EAS). EAS Hearing Implant System is currently under clinical investigation in the US. It is intended to provide the opportunity to detect and recognize auditory information through both electric and acoustic stimulation of the auditory nerve in the same ear. EAS is indicated for individuals with normal to moderate hearing loss sloping to severe/profound.

EAS takes a two-part approach: First, a cochlear implant electrically stimulates the nerve cells responsible for processing the high frequencies. Second, acoustic amplification is used to stimulate nerve cells responsible for processing low-frequency tones.

CAUTION - Investigational Device. Limited by Federal law to investigational use.

© 2017 MED-EL

We are using first- and third-party cookies which enable us to enhance site navigation, analyse site usage, and assist in our marketing efforts. Please click on 'Accept' to agree to the usage of cookies and hide this message permanently. You can find a list and description of the cookies used in our Cookie Policy.